These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 11111234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma.
    Aznar JA, Molina R, Montoro JM.
    Transfusion; 1999 Jul; 39(7):748-50. PubMed ID: 10413283
    [Abstract] [Full Text] [Related]

  • 5. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma.
    Hornsey VS, Krailadsiri P, MacDonald S, Seghatchian J, Williamson LM, Prowse CV.
    Br J Haematol; 2000 Jun; 109(3):665-70. PubMed ID: 10886222
    [Abstract] [Full Text] [Related]

  • 6. A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco-Tronic system.
    Hornsey VS, Drummond O, Young D, Docherty A, Prowse CV.
    Transfus Med; 2001 Feb; 11(1):31-6. PubMed ID: 11328569
    [Abstract] [Full Text] [Related]

  • 7. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M.
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6 days.
    von Heymann C, Keller MK, Spies C, Schuster M, Meinck K, Sander M, Wernecke KD, Kiesewetter H, Pruss A.
    Transfusion; 2009 May; 49(5):913-20. PubMed ID: 19159416
    [Abstract] [Full Text] [Related]

  • 15. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration.
    Hornsey VS, Young DA, Docherty A, Hughes W, Prowse CV.
    Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456
    [Abstract] [Full Text] [Related]

  • 16. Quality of methylene-blue-treated fresh-frozen plasma stored up to 27 months.
    Moog R, Reichenberg S, Hoburg A, Müller N.
    Transfusion; 2010 Feb; 50(2):516-8. PubMed ID: 20233360
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma.
    Zeiler T, Riess H, Wittmann G, Hintz G, Zimmermann R, Müller C, Heuft HG, Huhn D.
    Transfusion; 1994 Aug; 34(8):685-9. PubMed ID: 8073485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.